Computational Systems Biology Methods and Protocols.7z

(nextflipdebug5) #1
recognition through a new set of structural
alerts. Chem Rev 113(5):2940–2957.
https://doi.org/10.1021/cr300206t


  1. Toivonen H, Srinivasan A, King RD,
    Kramer S, Helma C (2003) Statistical evalua-
    tion of the Predictive Toxicology Challenge
    2000–2001. Bioinformatics 19
    (10):1183–1193.https://doi.org/10.1093/
    bioinformatics/btg130

  2. Sun HM (2004) Prediction of chemical carci-
    nogenicity from molecular structure. J Chem
    Inf Comput Sci 44(4):1506–1514.https://
    doi.org/10.1021/ci049917y

  3. Tanabe K, Lucic B, Amic D, Kurita T,
    Kaihara M, Onodera N, Suzuki T (2010) Pre-
    diction of carcinogenicity for diverse chemi-
    cals based on substructure grouping and SVM
    modeling. Mol Divers 14(4):789–802.
    https://doi.org/10.1007/s11030-010-
    9232-y

  4. Singh KP, Gupta S, Rai P (2013) Predicting
    carcinogenicity of diverse chemicals using
    probabilistic neural network modeling
    approaches. Toxicol Appl Pharmacol 272
    (2):465–475. https://doi.org/10.1016/j.
    taap.2013.06.029

  5. Li X, Du Z, Wang J, Wu Z, Li W, Liu G,
    Shen X, Tang Y (2015) In silico estimation
    of chemical carcinogenicity with binary and
    ternary classification methods. Mol Informat-
    ics 34(4):228–235. https://doi.org/10.
    1002/minf.201400127

  6. Aronov AM (2005) Predictive in silico mod-
    eling for hERG channel blockers. Drug Dis-
    cov Today 10(2):149–155.https://doi.org/
    10.1016/s1359-6446(04)03278-7

  7. Taboureau O, Jorgensen FS (2011) In silico
    predictions of hERG channel blockers in drug
    discovery: from ligand-based and target-based
    approaches to systems chemical biology.
    Comb Chem High Throughput Screen 14
    (5):375–387

  8. Cavero I, Mestre M, Guillon JM, Crumb W
    (2000) Drugs that prolong QT interval as an
    unwanted effect: assessing their likelihood of
    inducing hazardous cardiac dysrhythmias.
    Expert Opin Pharmacother 1(5):947–973.
    https://doi.org/10.1517/14656566.1.5.
    947

  9. Elliott DJ, Dondas NY, Munsey TS, Sivapra-
    sadarao A (2009) Movement of the S4 seg-
    ment in the hERG potassium channel during
    membrane depolarization. Mol Membr Biol
    26(8):435–447. https://doi.org/10.3109/
    09687680903321081

  10. Stansfeld PJ, Gedeck P, Gosling M, Cox B,
    Mitcheson JS, Sutcliffe MJ (2007) Drug


block of the hERG potassium channel: insight
from modeling. Proteins 68(2):568–580.
https://doi.org/10.1002/prot.21400


  1. Mitcheson JS, Chen J, Lin M, Culberson C,
    Sanguinetti MC (2000) A structural basis for
    drug-induced long QT syndrome. Proc Natl
    Acad Sci U S A 97(22):12329–12333.
    https://doi.org/10.1073/pnas.210244497

  2. Wang S, Li Y, Xu L, Li D, Hou T (2013)
    Recent developments in computational pre-
    diction of HERG blockage. Curr Top Med
    Chem 13(11):1317–1326. CTMC-EPUB-
    20130509-6 [pii]

  3. Pearlstein RA, Vaz RJ, Kang J, Chen XL,
    Preobrazhenskaya M, Shchekotikhin AE,
    Korolev AM, Lysenkova LN, Miroshnikova
    OV, Hendrix J, Rampe D (2003) Characteri-
    zation of HERG potassium channel inhibition
    using CoMSiA 3D QSAR and homology
    modeling approaches. Bioorg Med Chem
    Lett 13(10):1829–1835

  4. Wang W, MacKinnon R (2017) Cryo-EM
    structure of the open human ether-a-go-go-
    Related K+ Channel hERG. Cell 169
    (3):422–430 e410. S0092-8674(17)30410-
    5 [pii]. https://doi.org/10.1016/j.cell.
    2017.03.048

  5. Ekins S, Crumb WJ, Sarazan RD, Wikel JH,
    Wrighton SA (2002) Three-dimensional
    quantitative structure-activity relationship
    for inhibition of human ether-a-go-go-related
    gene potassium channel. J Pharmacol Exp
    Ther 301(2):427–434

  6. Cavalli A, Poluzzi E, De Ponti F, Recanatini
    M (2002) Toward a pharmacophore for drugs
    inducing the long QT syndrome: insights
    from a CoMFA study of HERG K(+) channel
    blockers. J Med Chem 45(18):3844–3853

  7. Inanobe A, Kamiya N, Murakami S,
    Fukunishi Y, Nakamura H, Kurachi Y
    (2008) In silico prediction of the chemical
    block of human ether-a-go-go-related gene
    (hERG) K+ current. J Physiol Sci 58
    (7):459–470. https://doi.org/10.2170/
    physiolsci.RV-0114-08-07-R1

  8. Aronov AM (2006) Common pharmaco-
    phores for uncharged human ether-a-go-go-
    related gene (hERG) blockers. J Med Chem
    49(23):6917–6921. https://doi.org/10.
    1021/jm060500o

  9. Springer C, Sokolnicki KL (2013) A finger-
    print pair analysis of hERG inhibition data.
    Chem Cent J 7(1):167.https://doi.org/10.
    1186/1752-153x-7-167

  10. Braga RC, Alves VM, Silva MF, Muratov E,
    Fourches D, Tropsha A, Andrade CH (2014)
    Tuning HERG out: antitarget QSAR models


Machine Learning-Based Modeling of Drug Toxicity 263
Free download pdf